Kazia Therapeutics
KZIA
7 hedge funds and large institutions have $127K invested in Kazia Therapeutics in 2013 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 1 closing their positions.
210% more capital invested
Capital invested by funds: $41K → $127K (+$86K)
200% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 1
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
40% more funds holding
Funds holding: 5 → 7 (+2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VKH
Virtu KCG Holdings
New York
|
+$70.3K |
| 2 |
U
UBS
Zurich,
Switzerland
|
+$15.4K |
| 3 |
Morgan Stanley
New York
|
+$14.4K |
| 4 |
BWFA
Baltimore-Washington Financial Advisors
Columbia,
Maryland
|
+$4.81K |
| 5 |
Citigroup
New York
|
+$1.93K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
-$9.62K |
| 2 |
PP
Palladium Partners
Norfolk,
Virginia
|
-$1K |
KZIA Hedge Fund Activity: Q4 2013 in Review
7 of the 3,459 institutional investors tracked by Wall St. Rank reported a position in Kazia Therapeutics (KZIA) for Q4 2013, worth a combined $127K — up 210% from $41K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new KZIA positions and 1 closed out — a net gain of 2 holders — while 2 added to existing stakes and 1 trimmed.
The largest buyer was Virtu KCG Holdings, opening a new position worth an estimated $70.3K. The largest seller was Bank of America, cutting an estimated $9.62K.
- 7 institutional investors held Kazia Therapeutics (KZIA) as of Q4 2013, up from 5 in Q3 2013.
- Funds reported $127K of Kazia Therapeutics stock for Q4 2013, up 210% quarter-over-quarter.
- 3 funds opened new Kazia Therapeutics positions in Q4 2013 and 1 closed out, a net change of +2 holders.
- The largest Kazia Therapeutics buyer in Q4 2013 was Virtu KCG Holdings, an estimated $70.3K added.
- The largest Kazia Therapeutics seller in Q4 2013 was Bank of America, an estimated $9.62K sold.
Based on aggregated 13F filings for Q4 2013.